January 04, 2012
Salix Pharmaceuticals to Present at J.P. Morgan Healthcare Conference
December 20, 2011
Salix Pharmaceuticals Completes Acquisition of Oceana Therapeutics
December 20, 2011
Salix and Progenics Announce Positive Highly Statistically Significant Results of Oral Methylnaltrexone for Phase 3 Trial in Chronic, Non-Cancer Pain Subjects with Opioid-Induced Constipation
December 14, 2011
Salix Pharmaceuticals Announces NDA Submission for Crofelemer for the Treatment of HIV-Associated Diarrhea
November 29, 2011
Salix Pharmaceuticals to Present at Oppenheimer Healthcare Conference
November 16, 2011
FDA Advisory Committee Supports Proposed Clinical Trial Design to Evaluate Repeat Treatment Cycles of XIFAXAN® for Irritable Bowel Syndrome with Diarrhea
November 08, 2011
Salix Pharmaceuticals to Acquire Oceana Therapeutics
November 08, 2011
Salix Pharmaceuticals Reports 3Q2011 Results and Raises 2011 Guidance
November 04, 2011
Salix Pharmaceuticals Previews Data Slated for Presentation at 62nd Annual Meeting of The American Association for The Study of Liver Diseases
November 03, 2011
Salix Pharmaceuticals to Present at Two Investment Conferences in November
October 28, 2011
Salix Pharmaceuticals Previews American College of Gastroenterology 2011
October 25, 2011
Salix Pharmaceuticals Announces 3Q2011 Financial Results Conference Call and Webcast
August 31, 2011
Salix Pharmaceuticals to Present at Three Investment Conferences in September
August 30, 2011
Progenics and Salix Announce FDA Acceptance of sNDA Filing For Relistor® in Patients With Non-Cancer Pain
August 08, 2011
Salix Pharmaceuticals Reports 2Q2011 Results
July 25, 2011
Salix Pharmaceuticals Announces 2Q2011 Financial Results Conference Call And Webcast
May 30, 2011
Salix Pharmaceuticals to Present at Three Investment Conferences in June
May 20, 2011
Salix Pharmaceuticals Reviews Data Presentations at American Pain Society Annual Meeting
May 09, 2011
Salix Pharmaceuticals Outlines Data Presentations at Digestive Disease Week 2011
May 09, 2011
Salix Pharmaceuticals Receives Lawsuit From Napo Pharmaceuticals
May 05, 2011
Salix Pharmaceuticals Reports 1Q2011 Results
April 25, 2011
Salix Pharmaceuticals to Present at Two Investment Conferences in May
April 21, 2011
Salix Pharmaceuticals Announces 1Q2011 Financial Results Conference Call And Webcast
April 20, 2011
Salix Pharmaceuticals Secures Additional Intellectual Property Relating To Rifaximin
April 06, 2011
Salix Pharmaceuticals Expands Rifaximin Collaboration With Lupin